subject: CHEBI:45863

object_name: Metastatic Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Hypopharyngeal squamous cell carcinoma recurrent

tested_intervention: unsure


subject: CHEBI:45863

object_name: Squamous cell carcinoma of the hypopharynx stage IV


subject: CHEBI:45863

object_name: Stage IV Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IVC Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IV Laryngeal Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVC Laryngeal Cancer AJCC v8


subject: CHEBI:45863

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: CHEBI:45863

object_name: Stage IV Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVC Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:45863

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:45863

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: MESH:C581747

subject_name: uromune

object_name: Recurrent urinary tract infections

tested_intervention: yes


subject: DRUGBANK:DB17605

object_name: congenital heart disease


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Head and neck cancer stage IV


subject: PUBCHEM.COMPOUND:14907381

object_name: Head and neck cancers - throat


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:80961

object_name: Neck Carcinoma


subject: CHEBI:80961

object_name: head and neck neoplasm


subject: CHEBI:80961

object_name: head and neck cancer


subject: CHEBI:80961


subject: CHEBI:80961


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: UNII:8375F9S90C

subject_name: Pamiparib


subject: UNII:8375F9S90C


subject: UNII:8375F9S90C


subject: UNII:8375F9S90C

object_name: head and neck squamous cell carcinoma


subject: UNII:8375F9S90C


subject: UNII:8375F9S90C


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Obesity, Visceral


subject: UMLS:C3713085

object_name: type 2 diabetes mellitus


subject: UMLS:C4765557

subject_name: dolutegravir / lamivudine

object_name: HIV infection


subject: UNII:CHZ6OLQ3UU

subject_name: pexelizumab

object_name: acute myocardial infarction


subject: UNII:CHZ6OLQ3UU

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0916853


subject: UMLS:C0916853


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: pediatric osteosarcoma


subject: UNII:6XC1PAD3KF

object_name: Osteosarcoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C4547427

subject_name: (18F)T807 compound

object_name: Chronic Traumatic Encephalopathy


subject: UMLS:C4547427

object_name: progressive supranuclear palsy


subject: UMLS:C4547427

object_name: Parkinson disease


subject: UMLS:C4547427

object_name: tauopathy


subject: UMLS:C4547427

object_name: Pick disease


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol

object_name: stroke disorder


subject: UNII:CLH5FT6412

object_name: cerebrovascular disorder


subject: UNII:CLH5FT6412

object_name: Stroke (heart beat)


subject: UNII:CLH5FT6412

object_name: Stroke, CTCAE


subject: UNII:CLH5FT6412

object_name: Intracranial Atherosclerosis


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030


subject: CHEBI:92994

subject_name: ambroxol

object_name: Dementia associated with Parkinson's Disease


subject: CHEBI:135590

subject_name: Ambroxol


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Bronchopulmonary Dysplasia, AE


subject: CHEBI:73604

object_name: congenital alveolar dysplasia


subject: CHEBI:73604

object_name: premature birth (history)


subject: CHEBI:8382

subject_name: Prednisone

object_name: Henoch-Schonlein purpura nephritis


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: DRUGBANK:DB08937

object_name: bladder tumor


subject: DRUGBANK:DB08937

object_name: urinary bladder carcinoma


subject: DRUGBANK:DB08937

object_name: urinary bladder cancer


subject: DRUGBANK:DB08937

object_name: childhood bladder carcinoma


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: esophagitis


subject: CHEBI:4806

object_name: Esophagitis, CTCAE


subject: CHEBI:4806

object_name: lung neoplasm


subject: CHEBI:31547

subject_name: Eplerenone

object_name: diabetic kidney disease


subject: UMLS:C0042210

subject_name: Vaccines

object_name: streptococcal pneumonia


subject: UMLS:C0042210

object_name: pneumococcal infection


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine


subject: CHEBI:78673

subject_name: cumene hydroperoxide


subject: UNII:KG6VO684Z6

subject_name: Polatuzumab vedotin


subject: UMLS:C3641728


subject: UNII:VUW370O5QE

subject_name: Cancidas

object_name: disseminated candidiasis


subject: UNII:VUW370O5QE

object_name: candidiasis, invasive


subject: PUBCHEM.COMPOUND:3035406

subject_name: Caspofungin


subject: PUBCHEM.COMPOUND:3035406


subject: UMLS:C1145191

subject_name: INJECTION, CASPOFUNGIN ACETATE, 5 MG


subject: UMLS:C1145191


subject: UMLS:C0935942


subject: UMLS:C0935942


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Refractory T Acute Lymphoblastic Leukemia


subject: CHEBI:133021

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:133021

object_name: Recurrent Childhood T Acute Lymphoblastic Leukemia


subject: CHEBI:133021

object_name: Recurrent T Acute Lymphoblastic Leukemia


subject: CHEBI:133021

object_name: Refractory T Lymphoblastic Lymphoma


subject: CHEBI:133021

object_name: Precursor B-lymphoblastic lymphoma refractory


subject: CHEBI:133021

object_name: Recurrent T Lymphoblastic Lymphoma


subject: CHEBI:133021

object_name: Precursor B-lymphoblastic lymphoma recurrent


subject: CHEBI:133021

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: PUBCHEM.COMPOUND:3717450


subject: CHEMBL.COMPOUND:CHEMBL3989979

subject_name: RIVOGENLECLEUCEL

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: plasma cell myeloma


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: leukemia


subject: CHEMBL.COMPOUND:CHEMBL3989979

object_name: childhood leukemia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: thyroid tumor


subject: UMLS:C1619396

subject_name: DEXAMETHASONE, ORAL, 0.25 MG ADMINISTERED


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: myocardial infarction


subject: CHEBI:38545

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:38545

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:38545

object_name: HMG COA reductase inhibitor adverse reaction


subject: UMLS:C1327963

object_name: ovarian cancer


subject: UMLS:C1327963

object_name: peritoneum cancer


subject: UMLS:C1327963

object_name: fallopian tube carcinoma


subject: UMLS:C1327963

object_name: fallopian tube cancer


subject: CHEBI:71219

subject_name: Pazopanib


subject: UNII:RC2V4W0EYC

subject_name: Buloxibutid

object_name: interstitial lung disease 2


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: traumatic encephalopathy


subject: CHEBI:135925

object_name: traumatic brain injury


subject: UMLS:C1963004

subject_name: White Bean (antigen)

object_name: Overweight and obesity


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: inborn error of immunity


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: hepatitis C


subject: PR:000017019

object_name: chronic hepatitis C virus infection


subject: UMLS:C5785760

subject_name: Gallium Ga 68 N188

object_name: neoplasm


subject: GTOPDB:12966

subject_name: cadonilimab

object_name: pleural mesothelioma


subject: GTOPDB:12966

object_name: malignant pleural mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL4594456

subject_name: CADONILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594456


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:27374

subject_name: Levoinositol

object_name: type 2 diabetes mellitus


subject: UMLS:C0937629

subject_name: Gymnema sylvestre preparation


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:24848

subject_name: inositol


subject: UMLS:C0544420

subject_name: Digestive Enzymes

object_name: irritable bowel syndrome


subject: UMLS:C5447315

subject_name: STING Agonist-containing PTGFRN-expressing Exosomes CDK002

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:85164

subject_name: Nintedanib

object_name: anthracosis


subject: CHEBI:85164

object_name: asbestosis


subject: CHEBI:85164

object_name: silicosis


subject: CHEBI:32599

object_name: Magnesium sulfate causing adverse effects in therapeutic use


subject: CHEBI:85993

subject_name: Palbociclib

object_name: pediatric osteosarcoma


subject: CHEBI:85993

object_name: Osteosarcoma


subject: CHEBI:55438

subject_name: Angiotensin 1-7

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:55438

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C0103306


subject: UMLS:C0103306


subject: UNII:LIA7Z4002P

subject_name: Nadroparin

object_name: acute kidney failure


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: delirium


subject: CHEBI:8874

object_name: Delirium, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: Acute respiratory infections


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: gonorrhea


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Thyroid cancer metastatic


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab


subject: UMLS:C1530450

subject_name: AMG 162


subject: CHEBI:80270

object_name: heart disorder


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UNII:6C9UKZ0CYE

object_name: chronic kidney disease


subject: UNII:6C9UKZ0CYE

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:15891

subject_name: Taurine

object_name: long COVID-19


subject: CHEBI:5551

subject_name: Guaifenesin

object_name: chronic rhinitis


subject: UMLS:C3659308

subject_name: Dantonic

object_name: Angina pectoris


subject: UNII:07O6708M02

subject_name: FENOBAM

object_name: Dysesthesia


subject: UNII:07O6708M02

object_name: Allodynia


subject: CHEBI:92728

subject_name: Fenobam


subject: CHEBI:92728


subject: CHEBI:27374

subject_name: Levoinositol

object_name: infertility


subject: CHEBI:27374

object_name: Hodgkin Disease


subject: CHEBI:27374

object_name: Irregular menstruation


subject: CHEBI:27372


subject: CHEBI:27372


subject: CHEBI:27372


subject: CHEBI:78337

subject_name: methyl isothiocyanate


subject: CHEBI:78337


subject: CHEBI:78337


subject: CHEBI:59059

subject_name: Methyl isocyanate


subject: CHEBI:59059


subject: CHEBI:59059


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:24848


subject: UMLS:C1530450

object_name: Allergy to denosumab


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Small cell lung cancer extensive stage


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: necrotizing soft tissue infection


subject: UMLS:C0085297

object_name: necrotizing fasciitis


subject: UMLS:C0085297

object_name: fournier gangrene


subject: UMLS:C0085297

object_name: gas gangrene


subject: MESH:C558471

subject_name: Hizentra


subject: MESH:C558471


subject: MESH:C558471


subject: MESH:C558471


subject: UNII:6897GXD6OE

object_name: Stomach cancer


subject: UNII:6897GXD6OE

object_name: gastric cancer


subject: UNII:6897GXD6OE

object_name: Surgery--Complications


subject: UNII:6897GXD6OE

object_name: Surgical procedure finding


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: colorectal cancer


subject: UNII:4EQZ6YO2HI

object_name: colorectal carcinoma


subject: UNII:4EQZ6YO2HI

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C4745001

subject_name: Porcupine Inhibitor RXC004


subject: UMLS:C4745001


subject: UMLS:C4745001


subject: CHEBI:66901

subject_name: Ivacaftor

object_name: Cystic fibrosis in children


subject: CHEBI:66901

object_name: Disorder of olfactory system


subject: CHEBI:66901

object_name: Olfactory Impairment


subject: CHEBI:66901

object_name: Parosmia


subject: UNII:RRN67GMB0V

subject_name: Elexacaftor


subject: UNII:RRN67GMB0V

object_name: chronic rhinosinusitis


subject: UNII:RRN67GMB0V


subject: UNII:RRN67GMB0V


subject: UNII:RRN67GMB0V


subject: UNII:8RW88Y506K

subject_name: Tezacaftor


subject: UNII:8RW88Y506K


subject: UNII:8RW88Y506K


subject: UNII:8RW88Y506K


subject: UNII:8RW88Y506K


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: psoriasis vulgaris


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: beta thalassemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: ependymoma


subject: UNII:2S9ZZM9Q9V

object_name: childhood ependymoma


subject: UNII:2S9ZZM9Q9V

object_name: Newly Diagnosed Childhood Ependymoma


subject: UNII:2S9ZZM9Q9V

object_name: anaplastic ependymoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Anaplastic Ependymoma


subject: PUBCHEM.COMPOUND:165411833

subject_name: PAFOLACIANINE

object_name: endometrial cancer


subject: PUBCHEM.COMPOUND:165411833

object_name: uterine corpus cancer


subject: PUBCHEM.COMPOUND:165411833

object_name: endometrial carcinoma


subject: UNII:F7BD3Z4X8L

subject_name: Pafolacianine


subject: UNII:F7BD3Z4X8L


subject: UNII:F7BD3Z4X8L


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Aspirin exacerbated respiratory disease


subject: CHEBI:41423

object_name: chronic rhinosinusitis with nasal polyps


subject: CHEBI:102029

subject_name: Sorbinil

object_name: diabetic retinopathy


subject: CHEBI:102029

object_name: diabetes mellitus


subject: CHEBI:125427

object_name: basal cell carcinoma


subject: CHEBI:125427

object_name: skin basal cell carcinoma


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: PUBCHEM.COMPOUND:152165


subject: PUBCHEM.COMPOUND:152165


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: UMLS:C5418055

subject_name: Glutamine Antagonist DRP-104

object_name: non-small cell lung carcinoma


subject: UMLS:C1815297

subject_name: Dakins Full Strength Solution

object_name: Diabetic foot ulcer


subject: CHEMBL.COMPOUND:CHEMBL461806

subject_name: ELTROMBOPAG OLAMINE

object_name: anemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Anemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: Adult Myelodysplastic Syndrome


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: juvenile myelomonocytic leukemia


subject: CHEMBL.COMPOUND:CHEMBL461806

object_name: chronic myelomonocytic leukemia


subject: UMLS:C1880492

subject_name: eltrombopag olamine


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: UMLS:C1880492


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Chronic coronary syndrome


subject: UNII:2S9ZZM9Q9V

object_name: Small cell lung cancer extensive stage


subject: CHEBI:90881

subject_name: Camptosar


subject: PUBCHEM.COMPOUND:67259771

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:67259771

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:67259771

object_name: Neoplasm Metastasis


subject: UMLS:C3272658

subject_name: cFMS Tyrosine Kinase Inhibitor ARRY-382


subject: UMLS:C3272658


subject: UMLS:C3272658


subject: CHEBI:91443

subject_name: c-FMS inhibitor


subject: CHEBI:91443


subject: CHEBI:91443


subject: CHEBI:28819

subject_name: Naringin

object_name: Weight loss


subject: CHEBI:28819

object_name: Weight Loss, CTCAE


subject: UMLS:C1957666

object_name: large cell carcinoma


subject: UMLS:C1957666

object_name: squamous cell carcinoma


subject: UMLS:C1957666

object_name: esophageal adenocarcinoma


subject: UMLS:C1957666

object_name: lung adenocarcinoma


subject: UMLS:C1957666

object_name: cervical adenocarcinoma


subject: UMLS:C1957666

object_name: adenocarcinoma


subject: UMLS:C1957666

object_name: bile duct adenocarcinoma


subject: UMLS:C1957666

object_name: gastric adenocarcinoma


subject: UMLS:C1709400


subject: UMLS:C1709400


subject: UMLS:C1709400


subject: UMLS:C1709400


subject: UMLS:C1709400


subject: UMLS:C1709400


subject: UMLS:C1709400


subject: UMLS:C1709400


subject: CHEBI:132268

subject_name: Dacomitinib


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: Barrett esophagus


subject: UMLS:C5417903

subject_name: FLT3/KIT/CSF1R Inhibitor NMS-03592088

object_name: chronic myelomonocytic leukemia


subject: UMLS:C5417903

object_name: adult acute myeloid leukemia


subject: UMLS:C5417903

object_name: childhood acute myeloid leukemia


subject: UMLS:C5417903

object_name: acute myeloid leukemia


subject: CHEBI:6801

subject_name: Metformin

object_name: neurobehavioral manifestations


subject: CHEBI:6801

object_name: intellectual disability


subject: CHEBI:6801

object_name: Trinucleotide Repeat Expansion


subject: CHEBI:6801

object_name: X-linked intellectual disability


subject: CHEBI:6801

object_name: sex-linked disease


subject: CHEBI:6801

object_name: X-linked disease


subject: CHEBI:17026

subject_name: Progesterone

object_name: Threatened miscarriage in first trimester


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: post-thrombotic syndrome


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:9824461

object_name: Control of hip fracture risk


subject: PUBCHEM.COMPOUND:9824461

object_name: Femur fracture


subject: UNII:R3I80TLN7S

subject_name: Milademetan

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C2742459

object_name: Alzheimer disease


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: impaired driving


subject: UMLS:C0678449

object_name: Cognitive impairment


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: hepatitis


subject: UNII:Q46947FE7K

object_name: Chronic hepatitis


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: UniProtKB:P36394

subject_name: SRY_RAT Sex-determining region Y protein (sprot)


subject: UniProtKB:P36394


subject: PR:000015643

subject_name: sex-determining region Y protein


subject: PR:000015643


subject: CHEBI:44915

subject_name: Propofol

object_name: abdominal aortic aneurysm


subject: CHEBI:44915

object_name: thoracic aortic aneurysm


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:6015


subject: UMLS:C1689829

subject_name: Civacir

object_name: transplantation infection


subject: UMLS:C1689829

object_name: Evidence of liver transplantation


subject: UMLS:C1689829

object_name: Sequelae of viral hepatitis


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Embolism


subject: CHEBI:68558

object_name: Embolus


subject: CHEBI:68558

object_name: aneurysm


subject: CHEBI:68558

object_name: Chest pain


subject: CHEBI:68558

object_name: Infarction


subject: CHEBI:87715

subject_name: Prasugrel


subject: CHEBI:87715


subject: CHEBI:87715


subject: CHEBI:87715

object_name: Angina pectoris


subject: CHEBI:87715


subject: CHEBI:87715


subject: CHEBI:87715

object_name: ischemia


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: Axial Spondyloarthritis


subject: MESH:D017077

subject_name: Culture Media, Conditioned

object_name: Chronic ulcer


subject: GTOPDB:12969

subject_name: tarlatamab

object_name: metastatic prostate carcinoma


subject: UNII:74X82ST8Q1

subject_name: TARLATAMAB


subject: UMLS:C4687660

subject_name: AMG 757


subject: CHEBI:9907

subject_name: ursodiol

object_name: Parkinson disease


subject: CHEBI:167638

subject_name: Labetalol

object_name: Drug-induced hypotension


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Neuropathic arthropathy due to diabetes mellitus


subject: UMLS:C4526674

subject_name: Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4526674

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4526674

object_name: sarcoma


subject: UMLS:C4526674

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4526674

object_name: soft tissue sarcoma


subject: UNII:FZ7NYF5N8L

subject_name: IRON SUCROSE

object_name: inflammatory bowel disease


subject: CHEBI:192761

subject_name: Iron sucrose


subject: CHEBI:8382

subject_name: Prednisone

object_name: endocrine exophthalmos


subject: CHEBI:16919

subject_name: Creatine


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: cytomegalovirus infection


subject: PUBCHEM.COMPOUND:57414794

object_name: Human Papilloma Virus, Female


subject: PUBCHEM.COMPOUND:57414794

object_name: Human Papilloma Virus, Male


subject: PUBCHEM.COMPOUND:57414794

object_name: EBV Infection


subject: PUBCHEM.COMPOUND:57414794

object_name: HHV8 Infection


subject: CHEBI:2639

subject_name: Amiloride

object_name: secondary progressive multiple sclerosis


subject: CHEBI:5118

subject_name: Fluoxetine


subject: CHEBI:8863

subject_name: Riluzole


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: trabecular adenocarcinoma


subject: UNII:W0ZE0NT8IF

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:W0ZE0NT8IF

object_name: endometrial cancer


subject: UNII:W0ZE0NT8IF

object_name: uterine corpus cancer


subject: UNII:W0ZE0NT8IF

object_name: endometrial carcinoma


subject: UNII:W0ZE0NT8IF

object_name: nonpapillary renal cell carcinoma


subject: UNII:W0ZE0NT8IF

object_name: clear cell renal carcinoma


subject: UNII:W0ZE0NT8IF

object_name: renal cell adenocarcinoma


subject: UNII:W0ZE0NT8IF

object_name: renal cell carcinoma


subject: UNII:W0ZE0NT8IF

object_name: bladder tumor


subject: UNII:W0ZE0NT8IF

object_name: urinary bladder carcinoma


subject: UNII:W0ZE0NT8IF

object_name: urinary bladder cancer


subject: UNII:W0ZE0NT8IF

object_name: childhood bladder carcinoma


subject: UNII:W0ZE0NT8IF

object_name: Childhood Breast Carcinoma


subject: UNII:W0ZE0NT8IF

object_name: breast carcinoma


subject: UNII:W0ZE0NT8IF

object_name: breast cancer


subject: UNII:W0ZE0NT8IF

object_name: melanoma


subject: GTOPDB:12349

subject_name: zimberelimab

object_name: gastroesophageal cancer


subject: GTOPDB:12349

object_name: trabecular adenocarcinoma


subject: GTOPDB:12349

object_name: cutaneous neuroendocrine carcinoma


subject: GTOPDB:12349

object_name: endometrial cancer


subject: GTOPDB:12349

object_name: uterine corpus cancer


subject: GTOPDB:12349

object_name: endometrial carcinoma


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349

object_name: colorectal cancer


subject: GTOPDB:12349

object_name: colorectal carcinoma


subject: GTOPDB:12349

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:12349

object_name: ovarian cancer


subject: GTOPDB:12349

object_name: ovarian neoplasm


subject: GTOPDB:12349

object_name: ovarian carcinoma


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL

object_name: renal cell adenocarcinoma


subject: UNII:ZBL7O904IL

object_name: renal cell carcinoma


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL

object_name: Childhood Breast Carcinoma


subject: UNII:ZBL7O904IL

object_name: breast carcinoma


subject: UNII:ZBL7O904IL

object_name: breast cancer


subject: UMLS:C5204520

object_name: gastroesophageal cancer


subject: UMLS:C5204520

object_name: trabecular adenocarcinoma


subject: UMLS:C5204520

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5204520

object_name: endometrial cancer


subject: UMLS:C5204520

object_name: uterine corpus cancer


subject: UMLS:C5204520

object_name: endometrial carcinoma


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: CHEBI:71952

subject_name: Dactolisib


subject: CHEBI:71952


subject: CHEBI:71952


subject: CHEBI:71952

object_name: Cowden disease


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: UMLS:C2347425


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: primary biliary cholangitis


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: Locally Advanced Rectal Carcinoma


subject: UNII:R8DG7T2D3A

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: UNII:R8DG7T2D3A

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:R8DG7T2D3A

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: UNII:R8DG7T2D3A

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: UNII:CLH5FT6412


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: CHEBI:46726


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: neoplasm of esophagus


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UNII:W9Y8L7GP4C

subject_name: Cetrotide

object_name: Encounter due to In vitro fertilization


subject: UMLS:C5238976

subject_name: Negalstobart

object_name: non-small cell lung carcinoma


subject: UMLS:C0035923

subject_name: Rubella Vaccine

object_name: Japanese encephalitis


subject: UMLS:C5397335

subject_name: Vaccine product containing only Rubella virus antigen (medicinal product)

object_name: rubella


subject: UMLS:C5397335

object_name: measles


subject: UMLS:C5397335

object_name: mumps


subject: UMLS:C5397335


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Depressed mood


subject: CHEBI:17650

object_name: Cancer patients and suicide and depression


subject: CHEBI:17650

object_name: Depressed - symptom


subject: CHEBI:17650

object_name: Depression, CTCAE


subject: RXCUI:8375

subject_name: placebo Oral Tablet


subject: RXCUI:8375


subject: RXCUI:8375


subject: RXCUI:8375


subject: CHEBI:57986

object_name: Unstable keratoconus


subject: UMLS:C3714502

subject_name: Riboflavin Drug Class


subject: CHEBI:17621

subject_name: FMN


subject: CHEBI:17015

subject_name: Riboflavin


subject: UMLS:C0722264

subject_name: Ontak

object_name: non-Hodgkin lymphoma


subject: UMLS:C0722264

object_name: Lymphoma, Low-Grade


subject: UMLS:C0722264

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:138684045

object_name: myasthenia gravis


subject: PUBCHEM.COMPOUND:138684045

object_name: Myasthenia Gravis, CTCAE


subject: PUBCHEM.COMPOUND:138684045

object_name: Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis


subject: UMLS:C5235868

object_name: rectal carcinoma


subject: UMLS:C5235868

object_name: rectal cancer


subject: UMLS:C5235868

object_name: Childhood Rectal Carcinoma


subject: CHEBI:50838

subject_name: Drospirenone

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:50838

object_name: metabolic syndrome X


subject: CHEBI:5132

subject_name: Flutamide


subject: CHEBI:5132


subject: CHEBI:261649

subject_name: Bismuth subsalicylate

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:261649

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:261649

object_name: morbid obesity


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Pre T-ALL


subject: CHEBI:52717

object_name: acute biphenotypic leukemia


subject: CHEBI:52717

object_name: mixed phenotype acute leukemia


subject: CHEBI:52717

object_name: acute leukemia of ambiguous lineage


subject: CHEBI:52717

object_name: T-Cell Lymphoma


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:70839


subject: CHEBI:70839


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:94265


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:64677


subject: CHEBI:64677


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41977


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:63612

subject_name: Nelarabine


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: CHEBI:63612


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: CHEBI:9555


subject: UMLS:C5856679

subject_name: Gallium Ga 68-PNT6555

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5856679

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5856679

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5856679

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5856679

object_name: sarcoma


subject: UMLS:C5856679

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5856679

object_name: soft tissue sarcoma


subject: UMLS:C5856679

object_name: cholangiocarcinoma


subject: UMLS:C5856679

object_name: colorectal cancer


subject: UMLS:C5856679

object_name: colorectal carcinoma


subject: UMLS:C5856679

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5856679

object_name: carcinoma of esophagus


subject: UMLS:C5856679

object_name: esophageal cancer


subject: UMLS:C5856679

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5856679

object_name: neoplasm of esophagus


subject: UMLS:C5856679

object_name: skin melanoma


subject: UMLS:C5856680

subject_name: Lutetium Lu 177-PNT6555


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C5856680


subject: UMLS:C0021027

subject_name: Immunoglobulins

object_name: pertussis


subject: UMLS:C0021027

object_name: Whooping cough


subject: UMLS:C0086333

subject_name: Gammagard


subject: UMLS:C0086333


subject: CHEBI:31932

subject_name: olmesartan

object_name: hyperlipidemia


subject: UMLS:C5556554

subject_name: Androgen Receptor Antagonist TQB3720

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UNII:7JNY4KV3NK

subject_name: OCIPERLIMAB

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5417829

subject_name: Ociperlimab


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:75551

object_name: chronic rhinosinusitis


subject: CHEBI:75551

object_name: Acquired deviated nasal septum


subject: CHEBI:75551

object_name: Congenital deviation of nasal septum


subject: CHEBI:75551

object_name: hypertrophy; mucous membrane nose (turbinate)


subject: CHEBI:75551

object_name: Nasal congestion


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C4521010

subject_name: AutoSynVax Vaccine

object_name: chronic hepatitis C virus infection


subject: UNII:4G4Z4676IS

subject_name: buciclovir


subject: PUBCHEM.COMPOUND:56674991

subject_name: Brincidofovir


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: High risk of


subject: CHEBI:41879

object_name: High risk


subject: CHEBI:41879

object_name: American College of Cardiology/American Heart Association Lesion Complexity Score C


subject: CHEBI:41879

object_name: High Risk Acute Leukemia


subject: CHEBI:41879

object_name: International Prognostic Index High Risk Group


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:63791


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:176724

subject_name: Etiracetam

object_name: bipolar depression


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: HMDB:HMDB0001349

subject_name: Selenium

object_name: heart failure


subject: HMDB:HMDB0001349

object_name: Heart Failure, CTCAE


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: UMLS:C0521939


subject: CHEBI:46245

subject_name: Ubidecarenone


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: peritoneal mesothelioma


subject: PUBCHEM.COMPOUND:14907381

object_name: malignant peritoneal mesothelioma


subject: PUBCHEM.COMPOUND:14907381

object_name: appendix cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: appendix carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410

object_name: peritoneal carcinomatosis


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816

object_name: ovarian neoplasm


subject: CHEBI:64816

object_name: digestive system cancer


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: ovarian cancer


subject: CHEBI:194095


subject: CHEBI:194095

object_name: ovarian carcinoma


subject: CHEBI:194095


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:87681

subject_name: Ranolazine

object_name: heart; dysfunction postoperative, cardiac surgery


subject: UMLS:C4733594

object_name: kidney failure


subject: CHEBI:229764

subject_name: Selinexor

object_name: leukemia


subject: CHEBI:229764

object_name: childhood leukemia


subject: UMLS:C3465369

subject_name: Mouthwash Product


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: periodontitis


subject: CHEBI:38721

subject_name: Methamidophos

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: thrombophilia


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Blood Clot


subject: CHEBI:135207

object_name: thrombosis


subject: CHEBI:135207

object_name: Thrombosis of blood vessel


subject: CHEBI:135207


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:91327

subject_name: Tivozanib

object_name: Stage II Renal Cell Cancer AJCC v8


subject: CHEBI:91327

object_name: Stage II Renal Cell Cancer


subject: CHEBI:91327

object_name: Stage II Renal Cell Cancer AJCC v7


subject: CHEBI:91327

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:91327

object_name: Stage III renal cell cancer


subject: CHEBI:91327

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C0034131

subject_name: Tubersol

object_name: HIV infection


subject: UMLS:C1725180

subject_name: ranibizumab ophthalmic

object_name: diabetic macular edema


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: kidney failure


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:44915

subject_name: Propofol

object_name: Venous puncture


subject: CHEBI:2569

subject_name: Alfentanil


subject: CHEBI:6413

subject_name: Letrozole

object_name: leiomyosarcoma of the corpus uteri


subject: PUBCHEM.COMPOUND:137319706

subject_name: Orforglipron

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:137319706

object_name: peripheral arterial disease


subject: UNII:7ZW40D021M

subject_name: ORFORGLIPRON


subject: UNII:7ZW40D021M


subject: CHEBI:134964

subject_name: Perflubutane

object_name: melanoma


subject: CHEBI:134964

object_name: skin melanoma


subject: MESH:C069727

subject_name: Sonazoid


subject: MESH:C069727


subject: DRUGBANK:DB18331

object_name: Hypothalamic obesity


subject: CHEBI:15891

subject_name: Taurine

object_name: periodontitis


subject: CHEBI:176381

subject_name: Diosmin

object_name: Lymphedema of lower extremity


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:27013

subject_name: Tocopherol


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: septic shock


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:15773

subject_name: cyclohexylamine

object_name: rectal carcinoma


subject: CHEBI:15773

object_name: rectal cancer


subject: CHEBI:15773

object_name: Childhood Rectal Carcinoma


subject: CHEBI:15773

object_name: Metastatic malignant neoplasm to liver


subject: CHEBI:15773

object_name: colon carcinoma


subject: CHEBI:15773

object_name: colorectal cancer


subject: CHEBI:15773

object_name: colon cancer


subject: UMLS:C5854667

object_name: malignant pleural mesothelioma


subject: UMLS:C2347401

subject_name: Oral Microencapsulated Diindolylmethane

object_name: Malignant neoplasm of female breast


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: Chronic uremia


subject: CHEBI:9288

subject_name: Streptozocin


subject: UMLS:C0113572

object_name: acne


subject: CHEBI:47657

subject_name: Roflumilast

object_name: Chronic small plaque psoriasis


subject: CHEBI:49603

subject_name: Lapatinib

object_name: ovarian cancer


subject: CHEBI:49603

object_name: ovarian neoplasm


subject: CHEBI:49603

object_name: ovarian carcinoma


subject: CHEBI:49603

object_name: peritoneum cancer


subject: UMLS:C0919144

subject_name: INJECTION, BASILIXIMAB, 20 MG Administered

object_name: end stage renal failure


subject: UMLS:C0919144


subject: UNII:9927MT646M

subject_name: Basiliximab


subject: UNII:9927MT646M


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Ann Arbor Stage III AIDS-Related Lymphoma


subject: CHEBI:4026

object_name: Ann Arbor Stage IV AIDS-Related Lymphoma


subject: CHEBI:4026

object_name: AIDS-Related Lymphoblastic Lymphoma


subject: CHEBI:4026

object_name: AIDS-Related Diffuse Mixed Cell Lymphoma


subject: CHEBI:4026

object_name: AIDS-Related Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:6520

subject_name: Lomustine


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:6520

object_name: Immunoblastic lymphoma associated with AIDS


subject: CHEBI:6520

object_name: AIDS-Related Diffuse Large Cell Lymphoma


subject: CHEBI:6520


subject: CHEBI:6520

object_name: Burkitt lymphoma associated with AIDS


subject: CHEBI:6520


subject: CHEBI:6520


subject: CHEBI:71417

subject_name: Procarbazine


subject: CHEBI:71417


subject: CHEBI:71417


subject: CHEBI:71417


subject: CHEBI:71417


subject: CHEBI:71417


subject: CHEBI:71417


subject: CHEBI:71417


subject: CHEBI:71417


subject: CHEBI:9449

subject_name: Terbutaline

object_name: type 1 diabetes mellitus


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: pleural cancer


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Post-Traumatic Headache


subject: UMLS:C0003438

subject_name: antithrombin III

object_name: Complication of transplanted liver


subject: UMLS:C0724532

subject_name: antithrombin III, human


subject: UMLS:C0723738

subject_name: Thrombate III


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: digestive system neuroendocrine tumor, grade 1/2


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Bone Resorption


subject: CHEBI:3311

object_name: Pregnant


subject: UMLS:C0378942

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: proliferative diabetic retinopathy


subject: CHEBI:9667

subject_name: Triamcinolone


subject: PUBCHEM.COMPOUND:104747

subject_name: Tegafur-uracil

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:0J0035E9FT

object_name: Low back pain


subject: UMLS:C3660936


subject: CHEBI:521033

subject_name: Dutasteride

object_name: Uses contraception (finding)


subject: CHEBI:6427

subject_name: Leuprolide


subject: MESH:C492535

subject_name: RotaTeq

object_name: Rotavirus infection


subject: MESH:C492535

object_name: HIV infection


subject: UNII:73SM5SF3OR

subject_name: Abrocitinib

object_name: food allergy


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:9800288

object_name: chronic obstructive pulmonary disease


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: UMLS:C3641717

subject_name: SUBA-itraconazole

object_name: prostate carcinoma


subject: UMLS:C3641717

object_name: prostate cancer


subject: CHEBI:53778

subject_name: Almitrine


subject: CHEBI:53778

object_name: Hypoxemic Respiratory Failure


subject: MESH:C000720852

object_name: head and neck squamous cell carcinoma


subject: MESH:C000720852

object_name: colorectal cancer


subject: MESH:C000720852

object_name: colorectal carcinoma


subject: MESH:C000720852

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4305694

object_name: cystic fibrosis


subject: MESH:C000726164

object_name: acute myeloid leukemia by FAB classification


subject: MESH:C000726164

object_name: acute myeloid leukemia


subject: CHEBI:50749

subject_name: Calcipotriol

object_name: Chronic small plaque psoriasis


subject: UNII:7G73627R36

subject_name: Chromanol


subject: UNII:7G73627R36


subject: UMLS:C3273941

subject_name: Androgen Antagonist APC-100


subject: UMLS:C3273941


subject: MESH:C118085

subject_name: superoxidized water

object_name: Ruptured Appendicitis


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight

object_name: infertility


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:50673

subject_name: Methimazole

object_name: glioblastoma


subject: CHEBI:50673

object_name: Childhood Glioblastoma


subject: CHEBI:50673

object_name: adult glioblastoma


subject: CHEBI:50673

object_name: glioma


subject: CHEBI:50673

object_name: malignant glioma


subject: UMLS:C0059079

subject_name: EMLA

object_name: Thalassemia in children


subject: UMLS:C4331846

object_name: Childhood Breast Carcinoma


subject: UMLS:C4331846

object_name: breast carcinoma


subject: UMLS:C4331846

object_name: breast cancer


subject: UMLS:C4331846

object_name: ovarian cancer


subject: UMLS:C4331846

object_name: ovarian neoplasm


subject: UMLS:C4331846

object_name: ovarian carcinoma


subject: UMLS:C2703106


subject: UMLS:C2703106


subject: UMLS:C2703106


subject: UMLS:C2703106


subject: UMLS:C2703106


subject: UMLS:C2703106


subject: CHEBI:91951

object_name: MAP2K2 Gene Mutation


subject: CHEBI:91951

object_name: MAP2K1 Gene Mutation


subject: CHEBI:91951

object_name: Solid carcinoma


subject: CHEBI:91951

object_name: malignant neoplasm of breast stage IV


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: PUBCHEM.COMPOUND:17756771


subject: CHEBI:88249

subject_name: Mirdametinib


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249


subject: CHEBI:88249

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:88249

object_name: Carcinoma breast stage IV


subject: CHEBI:88249


subject: CHEBI:88249

object_name: Her2-receptor negative breast cancer


subject: CHEBI:47781

subject_name: Desipramine

object_name: neurodegeneration with brain iron accumulation 2A


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin

object_name: end stage renal failure


subject: CHEMBL.COMPOUND:CHEMBL2108973

subject_name: INSULIN HUMAN, ISOPHANE

object_name: hyperglycemia


subject: CHEMBL.COMPOUND:CHEMBL2108973

object_name: Hyperglycemia, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108973

object_name: Glucose in blood specimen above reference range


subject: UMLS:C0795633

subject_name: insulin isophane, human


subject: UMLS:C0795633


subject: UMLS:C0795633


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: Pregnant


subject: CHEBI:10110

subject_name: Zidovudine


subject: UNII:739DM5514X

object_name: psychosis


subject: UNII:739DM5514X

object_name: Nonorganic psychosis


subject: UNII:739DM5514X

object_name: Psychosis, CTCAE


subject: UNII:739DM5514X

object_name: Aggressive behavior


subject: UNII:739DM5514X

object_name: Aggression


subject: UNII:739DM5514X

object_name: Presenile dementia


subject: UNII:739DM5514X

object_name: dementia


subject: UNII:739DM5514X

object_name: Agitation, CTCAE 3.0


subject: UNII:739DM5514X

object_name: Agitation


subject: UNII:739DM5514X

object_name: Agitation, CTCAE 5.0


subject: UNII:739DM5514X

object_name: Alzheimer disease


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: CHEBI:223115


subject: PUBCHEM.COMPOUND:11236066

subject_name: BRIMONIDINE TARTRATE

object_name: graft versus host disease


subject: PUBCHEM.COMPOUND:11236066

object_name: Ocular surface disease


subject: PUBCHEM.COMPOUND:11236066

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:3175

subject_name: Brimonidine


subject: CHEBI:3175


subject: CHEBI:3175


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic malignant neoplasm to peritoneum


subject: UMLS:C2346820


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592

object_name: peritoneum cancer


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: gallbladder cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640

object_name: malignant tumor of extrahepatic bile duct


subject: CHEBI:125354

subject_name: Plerixafor

object_name: brain neoplasm


subject: CHEBI:125354

object_name: Childhood Neuroblastoma


subject: CHEBI:125354

object_name: neuroblastoma


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors

object_name: anxiety


subject: UMLS:C0360105

object_name: anxiety disorder


subject: UMLS:C0360105

object_name: Anxiety symptoms


subject: UMLS:C0360105

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C0360105

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C0360105

object_name: Compulsion


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: rectal carcinoma


subject: UNII:GKF8S4C432

object_name: rectal cancer


subject: UNII:GKF8S4C432

object_name: Childhood Rectal Carcinoma


subject: UMLS:C1541521

subject_name: AMG 386

object_name: kidney failure


subject: UMLS:C1541521

object_name: kidney disorder


subject: UMLS:C1541521

object_name: impaired renal function disease


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C2348252

subject_name: Diclofenac Sodium Gel

object_name: head and neck neoplasm


subject: UMLS:C2348252

object_name: Childhood Breast Carcinoma


subject: UMLS:C2348252

object_name: breast carcinoma


subject: UMLS:C2348252

object_name: breast cancer


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Transitory tachypnea of newborn


subject: UMLS:C2078131

subject_name: intralesional corticosteroid injection

object_name: oral submucous fibrosis


subject: CHEBI:74704

subject_name: Met-Ile

object_name: Polycystic ovary syndrome of bilateral ovaries


subject: CHEBI:53620

subject_name: Methylisothiazolinone


subject: CHEBI:4285

subject_name: DCI


subject: UNII:U7NOE2K4M2

subject_name: Dichloroisoproterenol


subject: CHEBI:27372


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:134892

subject_name: Hexaminolevulinate

object_name: superficial urinary bladder carcinoma


subject: CHEBI:134892

object_name: Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: CHEBI:134892

object_name: High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:59495

subject_name: CIDOFOVIR

object_name: common wart


subject: CHEBI:530615


subject: CHEBI:134514


subject: CHEBI:3696

subject_name: Cidofovir


subject: CHEBI:75722

subject_name: Tramadol

object_name: acute pancreatitis


subject: UNII:YB18NF020M

subject_name: Satralizumab

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UNII:YB18NF020M

object_name: Delayed cerebral ischaemia


subject: CHEBI:45081

subject_name: Pentamidine

object_name: AIDS


subject: UMLS:C5389884

subject_name: insulin lispro-aabc

object_name: type 2 diabetes mellitus


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: liver failure


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:4305

subject_name: dacarbazine

object_name: Stage II Childhood Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Stage III Childhood Hodgkin Lymphoma


subject: CHEBI:4305

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: UNII:7XL5ISS668

subject_name: Adcetris


subject: UNII:7XL5ISS668


subject: UNII:7XL5ISS668


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: habitual spontaneous abortion


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:11306691

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:11306691

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:11306691

object_name: Serum lipids high (finding)


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:40237


subject: CHEBI:40237


subject: CHEBI:40237


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: UNII:6QVL057INT

object_name: skin carcinoma


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: CHEBI:83766

subject_name: Olaparib

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:83766

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:83766

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:83766

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:83766

object_name: Abnormality of DNA repair


subject: CHEBI:83766

object_name: metastatic prostate carcinoma


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: UNII:43Y934BBZ6

object_name: pancreatic adenocarcinoma


subject: UNII:43Y934BBZ6

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEMBL.COMPOUND:CHEMBL4297813


subject: CHEMBL.COMPOUND:CHEMBL4297813


subject: UMLS:C2827670

object_name: cardiovascular disorder


subject: UMLS:C2827670

object_name: lung disorder


subject: UMLS:C2827670

object_name: kidney disorder


subject: UMLS:C1564444

subject_name: Amchafibrin

object_name: osteoarthritis, knee


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection

object_name: Sedation complication


subject: CHEBI:135239

subject_name: Indobufen

object_name: atrial fibrillation


subject: CHEBI:135239

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:135239

object_name: Atrial Fibrillation, CTCAE


subject: UNII:9X7O8V25IT

subject_name: collagenase

object_name: male reproductive system disorder


subject: UNII:9X7O8V25IT

object_name: psychosexual disorder


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum


subject: UMLS:C0009053


subject: UMLS:C5706368

subject_name: Anti-B7-H3 Antibody-drug Conjugate HS-20093

object_name: malignant soft tissue neoplasm


subject: UMLS:C5706368

object_name: sarcoma


subject: CHEBI:145371

subject_name: Binimetinib

object_name: BRAF gene mutation


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: CHEBI:52172

subject_name: Nilotinib


subject: PUBCHEM.COMPOUND:139600705

subject_name: Pramlintide

object_name: Weight Gain


subject: PUBCHEM.COMPOUND:139600705

object_name: Weight Gain, CTCAE


subject: PUBCHEM.COMPOUND:139600705

object_name: schizophrenia


subject: PUBCHEM.COMPOUND:139600705

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:139600705

object_name: schizophrenia 18


subject: PUBCHEM.COMPOUND:139600705

object_name: Diabetes


subject: PUBCHEM.COMPOUND:139600705

object_name: diabetes mellitus


subject: CHEBI:139072

object_name: Advanced cancer


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:31824

subject_name: Mesna

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:31824

object_name: B-cell neoplasm


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: liver cirrhosis


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: systemic sclerosis


subject: CHEBI:6909

subject_name: Metronidazole


subject: UMLS:C1660716

subject_name: Razadyne ER

object_name: Alzheimer disease


subject: UMLS:C0701505

subject_name: Foscan

object_name: nasopharyngeal carcinoma


subject: UMLS:C0701505

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:9437

subject_name: Temoporfin


subject: CHEBI:9437


subject: CHEBI:6121

subject_name: Ketamine

object_name: chronic post-thoracotomy pain


subject: CHEBI:6121

object_name: Chronic post-thoracotomy pain syndrome


subject: CHEBI:31709

subject_name: Iohexol

object_name: lung disorder


subject: CHEBI:31709

object_name: History of - respiratory disease


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C5206860

subject_name: Rusfertide

object_name: Chronic anemia


subject: UMLS:C5206860

object_name: Anemia of inadequate production


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: HIV infection


subject: GTOPDB:12652

subject_name: magrolimab

object_name: Adult Myelodysplastic Syndrome


subject: GTOPDB:12652

object_name: childhood myelodysplastic syndrome


subject: GTOPDB:12652

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UNII:90YIEHRFJ9


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C3896840


subject: UMLS:C5782769

subject_name: BUPivacaine 0.5% injectable solution

object_name: Post-Operative Pain


subject: CHEBI:90936

subject_name: Alectinib

object_name: lung cancer


subject: CHEBI:90936

object_name: lung neoplasm


subject: CHEBI:90936

object_name: lung carcinoma


subject: CHEBI:90936

object_name: Anaplastic lymphoma kinase gene mutation


subject: CHEBI:90936

object_name: ALK Gene Translocation


subject: UMLS:C5447485

subject_name: Anti-OX40 Agonist Monoclonal Antibody YH-002

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5447487

subject_name: Anti-CTLA-4 Monoclonal Antibody YH001


subject: CHEBI:31536

subject_name: Emtricitabine

object_name: sexually transmitted disease


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: UMLS:C4051515

subject_name: PCSK9 Inhibitor [EPC]

object_name: aortic valve disease 2


subject: UMLS:C4051515

object_name: aortic stenosis


subject: UMLS:C4051515

object_name: aortic valve disease 3


subject: UMLS:C4051515

object_name: Stenosis of aorta


subject: UMLS:C5854359

subject_name: Anti-CTLA-4 Monoclonal Antibody-IL-15/IL-15Ra Fusion Protein JK08

object_name: cancer


subject: UMLS:C5854359

object_name: neoplasm


subject: UMLS:C5854359

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5854359

object_name: Embolism, Tumor


subject: UMLS:C5854359

object_name: Neoplasm Metastasis


subject: UMLS:C5854359


subject: UMLS:C5854359

object_name: thyroid tumor


subject: UMLS:C5854359

object_name: thyroid gland carcinoma


subject: UMLS:C5854359

object_name: thyroid cancer


subject: UMLS:C5854359

object_name: colorectal cancer


subject: UMLS:C5854359

object_name: colorectal carcinoma


subject: UMLS:C5854359

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854359

object_name: triple-negative breast carcinoma


subject: UMLS:C5854359

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5854359

object_name: Luminal breast cancer


subject: UMLS:C5854359

object_name: breast tumor luminal A or B


subject: UMLS:C5854359

object_name: non-small cell lung carcinoma


subject: UMLS:C5854359

object_name: gastroesophageal cancer


subject: UMLS:C5854359

object_name: ovarian carcinoma


subject: UMLS:C5854359

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5854359

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5854359

object_name: pancreatic adenocarcinoma


subject: UMLS:C5854359

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5854359

object_name: clear cell renal carcinoma


subject: UMLS:C5854359

object_name: papillary renal cell carcinoma


subject: UMLS:C5854359

object_name: skin squamous cell carcinoma


subject: UMLS:C5854359

object_name: colorectal adenocarcinoma


subject: UMLS:C5854359

object_name: liver carcinoma


subject: UMLS:C5854359

object_name: urothelial carcinoma


subject: UMLS:C5854359

object_name: transitional cell carcinoma


subject: UMLS:C5854359

object_name: gastric adenocarcinoma


subject: UMLS:C5854359

object_name: Childhood Solid Neoplasm


subject: UMLS:C5854359

object_name: Adult Solid Neoplasm


subject: UMLS:C5854359

object_name: Solid Neoplasm


subject: UMLS:C5854359

object_name: melanoma


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:85994

object_name: Embolism, Tumor


subject: CHEBI:85994

object_name: Neoplasm Metastasis


subject: CHEBI:85994

object_name: colorectal cancer


subject: CHEBI:85994

object_name: colorectal carcinoma


subject: CHEBI:85994

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:85994

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:85994

object_name: Luminal breast cancer


subject: CHEBI:85994

object_name: breast tumor luminal A or B


subject: CHEBI:85994

object_name: gastroesophageal cancer


subject: CHEBI:85994

object_name: pancreatic adenocarcinoma


subject: CHEBI:85994

object_name: papillary renal cell carcinoma


subject: CHEBI:85994

object_name: skin squamous cell carcinoma


subject: CHEBI:85994

object_name: colorectal adenocarcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: open-angle glaucoma


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C2826386

object_name: Solid Neoplasm


subject: CHEBI:4495

subject_name: Diazoxide

object_name: craniopharyngioma


subject: CHEBI:64073

object_name: sleep apnea


subject: UNII:9P1872D4OL

subject_name: Exenatide


subject: CHEBI:44915

subject_name: Propofol

object_name: Sedative adverse reaction


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: septooptic dysplasia


subject: CHEBI:5931

subject_name: insulin human


subject: PUBCHEM.COMPOUND:134612761

subject_name: macimorelin


subject: UMLS:C5706286

subject_name: Jing Si Herbal Tea

object_name: bladder tumor


subject: UMLS:C5706286

object_name: urinary bladder carcinoma


subject: UMLS:C5706286

object_name: urinary bladder cancer


subject: UMLS:C5706286

object_name: childhood bladder carcinoma


subject: UMLS:C5706286

object_name: lower urinary tract symptom


subject: UMLS:C5706286

object_name: Herbal interaction


subject: UMLS:C5706286

object_name: Intravenous Drug Usage


subject: DRUGBANK:DB18226

subject_name: Belcesiran

object_name: alpha 1-antitrypsin deficiency


subject: CHEBI:6775

subject_name: Mesalazine

object_name: Lynch syndrome


subject: CHEBI:6775

object_name: Hereditary Nonpolyposis Colorectal Cancer


subject: CHEBI:6775

object_name: Colon Neoplasm


subject: CHEBI:6775

object_name: benign colon neoplasm


subject: CHEBI:6775

object_name: colon carcinoma


subject: CHEBI:6775

object_name: colon cancer


subject: UMLS:C0879396

object_name: Embolism, Tumor


subject: UMLS:C0879396

object_name: Neoplasm Metastasis


subject: UMLS:C0879396

object_name: Metastatic Lesion


subject: UMLS:C0879396

object_name: carcinoma


subject: UMLS:C0879396

object_name: childhood neoplasm


subject: UMLS:C0879396

object_name: neoplastic syndrome


subject: UMLS:C0879396

object_name: cancer or benign tumor


subject: UMLS:C0879396

object_name: neoplasm


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: HIV-1 infection


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:63633

subject_name: Triptorelin

object_name: Malignant neoplasm of female breast


subject: CHEBI:31705

subject_name: Iodixanol

object_name: hypothyroidism


subject: CHEBI:31705

object_name: Hypothyroidism, CTCAE


subject: CHEBI:31709

subject_name: Iohexol


subject: CHEBI:31709


subject: CHEBI:63578

subject_name: Iopromide


subject: CHEBI:63578


subject: CHEBI:31717

subject_name: Ioversol


subject: CHEBI:31717


subject: UMLS:C4305713

object_name: cystic fibrosis


subject: CHEBI:8499

subject_name: Propranolol

object_name: congenital heart disease


subject: CHEBI:8499

object_name: Chylothorax, CTCAE


subject: CHEBI:8499

object_name: Chylothorax


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: ovarian endometriosis


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: PUBCHEM.COMPOUND:24956525

subject_name: Tyrosine kinase inhibitor

object_name: Neoplasm, Residual


subject: UMLS:C1268567

subject_name: Protein-tyrosine kinase inhibitor


subject: UNII:RDF76R62ID

subject_name: LAROTRECTINIB SULFATE

object_name: Recurrent Acute Leukemia


subject: UNII:RDF76R62ID

object_name: Refractory Acute Leukemia


subject: UNII:RDF76R62ID

object_name: Solid Neoplasm


subject: UNII:RDF76R62ID

object_name: Adult Central Nervous System Neoplasm


subject: UNII:RDF76R62ID

object_name: Childhood Central Nervous System Neoplasm


subject: UNII:RDF76R62ID

object_name: central nervous system neoplasm


subject: UNII:RDF76R62ID

object_name: central nervous system cancer


subject: UNII:RDF76R62ID

object_name: Malignant neoplasm of the central nervous system


subject: UNII:RDF76R62ID

object_name: congenital fibrosarcoma


subject: UNII:PF9462I9HX

subject_name: Larotrectinib


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: UNII:PF9462I9HX


subject: CHEBI:167574

subject_name: Semaglutide

object_name: hyperglycemia


subject: CHEBI:167574

object_name: Hyperglycemia, CTCAE


subject: CHEBI:167574

object_name: Glucose in blood specimen above reference range


subject: CHEBI:167574

object_name: Primary non-function of renal transplant


subject: UMLS:C1506837

object_name: prostate carcinoma


subject: UMLS:C1506837

object_name: prostate cancer


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: polyostotic fibrous dysplasia


subject: CHEBI:8869

object_name: McCune-Albright syndrome


subject: CHEBI:8869

object_name: fibrous dysplasia


subject: MESH:C000722934

subject_name: CVnCoV COVID-19 vaccine

object_name: Post vaccination fever


subject: MESH:C000722934

object_name: Febrile Seizure


subject: MESH:C000722934

object_name: Fever


subject: MESH:C000722934

object_name: Fever symptoms (finding)


subject: MESH:C000722934

object_name: Fever, CTCAE


subject: UNII:RJ1IW3B4QX

subject_name: Tezepelumab

object_name: eosinophilic esophagitis


subject: UNII:RJ1IW3B4QX

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C1615643

subject_name: Eperisone hydrochloride

object_name: Acute back pain


subject: CHEBI:3724

subject_name: citalopram hydrobromide

object_name: schizophrenia


subject: UMLS:C0086413

subject_name: HIV Vaccine

object_name: Human Immunodeficiency Virus Positive


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:177413

subject_name: Plinabulin

object_name: plasma cell myeloma


subject: UMLS:C1741609


subject: CHEBI:2677

subject_name: Augmentin

object_name: Community-Acquired Pneumonia


subject: RXCUI:151392


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: Posttransplant diabetes mellitus


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: infertility


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:167309

subject_name: Methadone

object_name: spinal stenosis


subject: CHEBI:167309

object_name: Degenerative spondylolisthesis


subject: CHEBI:167309

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:167309

object_name: Back pain


subject: CHEBI:167309

object_name: Back Pain, CTCAE 3.0


subject: UMLS:C0732225

subject_name: Octaplas

object_name: Decreased liver function


subject: UMLS:C0732225

object_name: blood coagulation disease


subject: UMLS:C0242402

subject_name: Opioids

object_name: acute pancreatitis


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Disorder of vitamin D


subject: CHEBI:7931

subject_name: Paricalcitol


subject: UMLS:C0906802

object_name: Systemic sclerosis [scleroderma]


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: vernal keratoconjunctivitis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: PUBCHEM.COMPOUND:71289877

object_name: Crohn disease


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Chronic uremia


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: peripheral nervous system disorder


subject: UMLS:C3714803

object_name: neuropathy


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:30584

object_name: Brittle hair


subject: CHEBI:30584

object_name: Xeroderma


subject: CHEBI:30584

object_name: Dry Skin, CTCAE


subject: CHEBI:30584

object_name: Dry skin


subject: CHEBI:30584

object_name: Fine hair


subject: CHEBI:30584

object_name: alopecia


subject: CHEBI:30584

object_name: Dry hair


subject: CHEBI:30563

subject_name: Silicon dioxide


subject: CHEBI:30563


subject: CHEBI:30563


subject: CHEBI:30563


subject: CHEBI:30563


subject: CHEBI:30563


subject: CHEBI:30563


subject: UMLS:C3652543

subject_name: sodium levofolinate

object_name: pancreatic neoplasm


subject: UMLS:C3652543

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3652543

object_name: malignant pancreatic neoplasm


subject: CHEBI:2955

subject_name: Azithromycin

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:2955

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:2955

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:5801


subject: CHEBI:5801


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Breast neoplasm female


subject: CHEBI:4672

subject_name: Docetaxel


subject: UMLS:C5555581

subject_name: Inetetamab


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: CHEBI:84040


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C5206815

object_name: non-small cell lung carcinoma


subject: PR:000004266

subject_name: AT-rich interactive domain-containing protein 3B

object_name: COPD, severe early onset


subject: PR:000004266

object_name: chronic obstructive pulmonary disease


subject: UMLS:C3896896

subject_name: Letolizumab

object_name: graft versus host disease


subject: UMLS:C3896896

object_name: acute graft versus host disease


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:2S9ZZM9Q9V

object_name: testicular lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: intraocular lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Mantle cell lymphoma stage IV


subject: UNII:2S9ZZM9Q9V

object_name: small intestine lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Immunoblastic Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Burkitt lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Burkitt Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: hepatosplenic T-cell lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Large Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Childhood Large Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: primary cutaneous B-cell lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Childhood Burkitt Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: splenic marginal zone lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: MALT lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: noncutaneous extranodal lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: T-cell large granular lymphocyte leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UNII:2S9ZZM9Q9V

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:2S9ZZM9Q9V

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: UNII:2S9ZZM9Q9V

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:2S9ZZM9Q9V

object_name: refractory hairy cell leukemia


subject: UNII:2S9ZZM9Q9V

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: Waldenstrom macroglobulinemia


subject: UNII:68AYS9A614

subject_name: CEDIRANIB MALEATE

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: anaplastic large cell lymphoma


subject: UNII:68AYS9A614

object_name: testicular lymphoma


subject: UNII:68AYS9A614

object_name: intraocular lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: UNII:68AYS9A614

object_name: angioimmunoblastic T-cell lymphoma


subject: UNII:68AYS9A614

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:68AYS9A614

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Mantle cell lymphoma recurrent


subject: UNII:68AYS9A614

object_name: Mantle cell lymphoma stage IV


subject: UNII:68AYS9A614

object_name: small intestine lymphoma


subject: UNII:68AYS9A614

object_name: Childhood Immunoblastic Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UNII:68AYS9A614

object_name: unspecified childhood solid tumor, protocol specific


subject: UNII:68AYS9A614

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UNII:68AYS9A614

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:68AYS9A614

object_name: Burkitt lymphoma


subject: UNII:68AYS9A614

object_name: Childhood Burkitt Lymphoma


subject: UNII:68AYS9A614

object_name: hepatosplenic T-cell lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Childhood Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:68AYS9A614

object_name: primary cutaneous B-cell lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Childhood Burkitt Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Adult Burkitt Lymphoma


subject: UNII:68AYS9A614

object_name: nodal marginal zone B-cell lymphoma


subject: UNII:68AYS9A614

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UNII:68AYS9A614

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UNII:68AYS9A614

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UNII:68AYS9A614

object_name: splenic marginal zone lymphoma


subject: UNII:68AYS9A614

object_name: MALT lymphoma


subject: UNII:68AYS9A614

object_name: noncutaneous extranodal lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UNII:68AYS9A614

object_name: Stage IV Adult Burkitt Lymphoma


subject: UNII:68AYS9A614

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UNII:68AYS9A614

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: UNII:68AYS9A614

object_name: T-cell large granular lymphocyte leukemia


subject: UNII:68AYS9A614

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UNII:68AYS9A614

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UNII:68AYS9A614

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: UNII:68AYS9A614

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:68AYS9A614

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UNII:68AYS9A614

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: UNII:68AYS9A614

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:68AYS9A614

object_name: refractory hairy cell leukemia


subject: UNII:68AYS9A614

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UNII:68AYS9A614

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:68AYS9A614

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UNII:68AYS9A614

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C2711999

subject_name: cediranib maleate

object_name: Adult Anaplastic Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C2711999

object_name: anaplastic large cell lymphoma


subject: UMLS:C2711999

object_name: testicular lymphoma


subject: UMLS:C2711999

object_name: intraocular lymphoma


subject: UMLS:C2711999

object_name: Stage IV Adult Lymphoblastic Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Lymphoblastic Lymphoma


subject: UMLS:C2711999

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C2711999

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UMLS:C2711999

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C2711999

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C2711999

object_name: Mantle cell lymphoma stage IV


subject: UMLS:C2711999

object_name: small intestine lymphoma


subject: UMLS:C2711999

object_name: Childhood Immunoblastic Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C2711999

object_name: unspecified childhood solid tumor, protocol specific


subject: UMLS:C2711999

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: UMLS:C2711999

object_name: Childhood Diffuse Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UMLS:C2711999

object_name: Burkitt lymphoma


subject: UMLS:C2711999

object_name: Childhood Burkitt Lymphoma


subject: UMLS:C2711999

object_name: hepatosplenic T-cell lymphoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Childhood Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Burkitt Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UMLS:C2711999

object_name: primary cutaneous B-cell lymphoma


subject: UMLS:C2711999

object_name: Stage IV Childhood Burkitt Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C2711999

object_name: Recurrent Adult Burkitt Lymphoma


subject: UMLS:C2711999

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C2711999

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: UMLS:C2711999

object_name: Ann Arbor Stage IV Grade 3 Follicular Lymphoma


subject: UMLS:C2711999

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: UMLS:C2711999

object_name: splenic marginal zone lymphoma


subject: UMLS:C2711999

object_name: MALT lymphoma


subject: UMLS:C2711999

object_name: noncutaneous extranodal lymphoma


subject: UMLS:C2711999

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UMLS:C2711999

object_name: Stage IV Adult Burkitt Lymphoma


subject: UMLS:C2711999

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UMLS:C2711999

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: UMLS:C2711999

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C2711999

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: UMLS:C2711999

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C2711999

object_name: childhood nasal type extranodal NK/T-cell lymphoma


subject: UMLS:C2711999

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C2711999

object_name: Adult T-cell lymphoma/leukaemia stage IV


subject: UMLS:C2711999

object_name: Childhood Grade III Lymphomatoid Granulomatosis


subject: UMLS:C2711999

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UMLS:C2711999

object_name: refractory hairy cell leukemia


subject: UMLS:C2711999

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: UMLS:C2711999

object_name: Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2711999

object_name: Stage IVA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: UMLS:C2711999

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:231679

subject_name: ipilimumab

object_name: metastatic neoplasm


subject: UMLS:C4722744

subject_name: Pexa-vec


subject: UMLS:C4722744

object_name: Embolism, Tumor


subject: UMLS:C4722744

object_name: Neoplasm Metastasis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: nicotine dependence


subject: UMLS:C5206750

subject_name: Eltivutabart

object_name: pancreatic neoplasm


subject: UMLS:C5206750

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5206750

object_name: malignant pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297858

subject_name: BUDIGALIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297858


subject: CHEMBL.COMPOUND:CHEMBL4297858


subject: UMLS:C4527193


subject: UMLS:C4527193


subject: UMLS:C4527193


subject: CHEBI:90687

object_name: neoplasm


subject: CHEBI:90687

object_name: adult lymphoma


subject: CHEBI:90687

object_name: lymphoma


subject: CHEBI:90687

object_name: pediatric lymphoma


subject: UMLS:C1831929


subject: UMLS:C1831929


subject: UMLS:C1831929


subject: UMLS:C1831929


subject: PUBCHEM.COMPOUND:73352623

subject_name: Pbmc

object_name: Stage IV Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:73352623

object_name: Stage IV Colorectal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:73352623

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:73352623

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:73352623

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:73352623

object_name: Colorectal cancer recurrent


subject: PUBCHEM.COMPOUND:73352623

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:73352623

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:73352623

object_name: Pancreatic carcinoma stage IVA


subject: PUBCHEM.COMPOUND:73352623

object_name: Stage IVB Pancreatic Cancer


subject: PUBCHEM.COMPOUND:73352623

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:73352623

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:73352623

object_name: Recurrent Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:73352623

object_name: metastatic malignant neoplasm in the brain


subject: PUBCHEM.COMPOUND:73352623

object_name: Unresectable Solid Neoplasm


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: pelvic inflammatory disease


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:63633

subject_name: Triptorelin

object_name: endometriosis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:9241

object_name: obesity


subject: CHEBI:9241

object_name: Obesity, CTCAE


subject: CHEBI:9241

object_name: Insulin resistance


subject: CHEBI:32231

subject_name: Tipepidine hibenzate

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:135141

subject_name: Tipepidine


subject: UMLS:C0145968

subject_name: tipepidine hibenzate


subject: UMLS:C4309517

object_name: Advanced cancer


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Paroxysmal Atrial Fibrillation by ECG Finding


subject: CHEBI:63619

subject_name: Propafenone

object_name: paroxysmal atrial fibrillation


subject: CHEBI:63619


subject: CHEBI:28593

subject_name: Quinidine


subject: CHEBI:28593


subject: CHEBI:4681

subject_name: Dofetilide


subject: CHEBI:4681


subject: CHEBI:63622

subject_name: Sotalol


subject: CHEBI:63622


subject: CHEBI:135083

subject_name: Cibenzoline


subject: CHEBI:135083


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: UMLS:C0006684


subject: UMLS:C0003195

subject_name: Anti-Arrhythmia Agents


subject: UMLS:C0003195


subject: CHEBI:48273

subject_name: Rizatriptan

object_name: Migrainous vertigo


subject: UMLS:C5235865

object_name: adult acute myeloid leukemia


subject: UMLS:C5235865

object_name: childhood acute myeloid leukemia


subject: UMLS:C5235865

object_name: acute myeloid leukemia


subject: UNII:08W354EC17

object_name: non-small cell lung carcinoma


subject: UMLS:C3274841

subject_name: Iodine I 124 NM404


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Ear pain


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Febrile Seizure


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: chronic kidney disease


subject: UMLS:C0003442

object_name: kidney failure


subject: UNII:E3B2GI648A

subject_name: Belatacept


subject: UNII:E3B2GI648A


subject: CHEBI:8249

subject_name: Piroxicam

object_name: Dysmenorrhea, CTCAE


subject: CHEBI:8249

object_name: Dysmenorrhea


subject: CHEBI:63634

subject_name: Valdecoxib


subject: CHEBI:63634


subject: CHEBI:31530

subject_name: Edaravone

object_name: Drug Interactions


subject: CHEBI:9123

subject_name: Sertraline

object_name: type 2 diabetes mellitus


subject: CHEBI:9123

object_name: Diabetes


subject: CHEBI:9123

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest

object_name: Uses contraception (finding)


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: melanoma


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Thumb osteoarthritis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: influenza


subject: CHEBI:60648

subject_name: DOXYCYCLINE


subject: CHEBI:60648

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:60648

object_name: cardio-renal syndrome


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: UMLS:C0359156

subject_name: Thymoglobulin

object_name: Kidney transplant failure and rejection


subject: UMLS:C5700342

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5700342

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5700342

object_name: sarcoma


subject: UMLS:C5700342

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5700342

object_name: soft tissue sarcoma


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: UMLS:C1618336

subject_name: Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries

object_name: renal carcinoma


subject: UMLS:C1618336

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: periodontitis


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:TTT1F11FZB

object_name: schizophrenia


subject: CHEBI:85990

subject_name: Panobinostat

object_name: Recurrent Glioma


subject: CHEBI:85990

object_name: metastatic malignant neoplasm in the brain